Behind Pfizer and Moderna in COVID Vaccine War, Novavax Files for Vax Authorization in the UK
Posted on 10/27/2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company announced the completion of its rolling regulatory submission to the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for authorization of its COVID-19 vaccine candidate. The company’s application for Conditional Marketing Authorization (CMA) marks the first submission for authorization of a protein-based COVID-19 vaccine in the United Kingdom. […]
